The University of Oxford announces a major breakthrough in the vaccination campaign against malaria. The R21-Matrix-M vaccine has been administered to over 450 children in Burkina Faso and proved to have a "high-level efficacy" of around 77%. Malaria currently kills an estimated 400,000 people per year, mostly in sub-Saharan Africa.
The University of Oxford announces a major breakthrough in vaccination against malaria. The vaccine was applied to over 450 children in Burkina Faso and proved "high-level efficiency" of around 77%. Malaria currently kills an estimated 400,000 people per year, mostly in sub-Saharan Africa.
The University of Oxford announces a major breakthrough in vaccination against malaria. The R21-Matrix-Mvaccine was applied to over 450 children in Burkina Faso and proved "high-level efficacy" of around 77%. Malaria currently kills an estimated 400,000 people per year, mostly in sub-Saharan Africa.
The University of Oxford announces a major breakthrough in vaccination against malaria. The R21-Matrix-M vaccine was administered to over 450 children in Burkina Faso and proved "high-level efficacy" of around 77%. Malaria currently kills an estimated 400,000 people per year, mostly in sub-Saharan Africa.
The University of Oxford announces a major breakthrough in thevaccination campaignagainst malaria. The R21-Matrix-M vaccine has beenadministered to over 450 children in Burkina Faso and provedtohavea "high-level efficacy" of around 77%. Malaria currently kills an estimated 400,000 people per year, mostly in sub-Saharan Africa.
